Fierce Healthcare May 6, 2022
Heather Landi

Tech company Tempus has notched a partnership with the Department of Veterans Affairs (VA) to provide patients with cancer access to cutting-edge genetic testing to improve treatment.

The VA is the largest healthcare system in the U.S., comprising over 1,000 healthcare facilities including 171 VA medical centers. It’s Tempus’ largest health system partnership to date.

There are 9 million veterans served by the VA health system. It’s estimated there are approximately 40,000 new cancer cases in veterans reported annually. And as the veteran population continues to age, this number will continue to rise.

Through a multiyear agreement, the VA’s National Precision Oncology Program will have access to Tempus’ portfolio of next-generation sequencing offerings to support...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Partnerships, Pharma / Biotech, Precision Medicine, Provider, Technology, Trends, VA / DoD
Global Genetics Study of 1.7M People Finds New Depression Risk Variants
New Liver Cancer Models Could Enable Precision Medicine
Detecting Cancer Before Symptoms? Multicancer Early Detection Leads the Way
“Precision Med Has Evolved as Badly As I Expected” And Other Takeaways From Former FDA Commissioner At PMWC
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine

Share This Article